A fraction of the transcription factor TAF15 participates in interactions with a subset of the spliceosomal U1 snRNP complex

https://doi.org/10.1016/j.bbapap.2011.09.008Get rights and content

Abstract

RNA/ssDNA-binding proteins comprise an emerging class of multifunctional proteins with an anticipated role in coupling transcription with RNA processing. We focused here on the highly related transcription factors of the TET sub-class: TLS/FUS, EWS and in particular the least studied member TAF15. An extensive array of immunoprecipitation studies on differentially extracted HeLa nuclei revealed the specific association of TAF15 with the spliceosomal U1 snRNP complex, as deduced by the co-precipitating U1 snRNA, U1-70 K and Sm proteins. Additionally, application of anti-U1 RNP autoantibodies identified TAF15 in the immunoprecipitates. Minor fractions of nuclear TAF15 and U1 snRNP were involved in this association. Pull-down assays using recombinant TAF15 and U1 snRNP-specific proteins (U1-70 K, U1A and U1C) provided in vitro evidence for a direct protein–protein interaction between TAF15 and U1C, which required the N-terminal domain of TAF15. The ability of TAF15 to directly contact RNA, most likely RNA pol II transcripts, was supported by in vivo UV cross-linking studies in the presence of α-amanitin. By all findings, the existence of a functionally discrete subset of U1 snRNP in association with TAF15 was suggested and provided further support for the involvement of U1 snRNP components in early steps of coordinated gene expression.

Highlights

► The transcription factor TAF15 can associate with the spliceosomal U1 snRNP complex. ► TAF15 can make direct interactions with the U1C protein, in vitro. ► TAF15 can directly contact RNA, in vivo.

Introduction

It is becoming increasingly clear that an extensive network of interactions between structurally distinct macromolecular assemblies coordinates and couples all events of mRNA metabolism in higher eukaryotes [1], [2]. The interactions involve factors of the transcriptional machinery, as well as of the post-transcriptional apparatus that refer to 5′ capping, splicing and polyadenylation steps acting co-transcriptionally [3], [4]. In particular, the coupling between transcription and splicing has been extensively analyzed and shown to involve a network of interactions between components of the basal transcriptional machinery and a large macromolecular assembly, the spliceosome [5], [6].

With respect to the transcriptional machinery, special reference is made to the role of TFIID complex, composed of the TATA-binding protein (TBP) in association with general and specific transcription factors (TAFIIs) [7], [8], as well as to the RNA pol II and, in particular, the carboxy-terminal domain (CTD) of its largest subunit [9]. As for the splicing factors, these refer to an extensive array of RNA-binding proteins, including members of the SR and hnRNP protein family for both basal and alternative splicing events, as well as to the spliceosomal U-snRNP (uridine-rich small nuclear ribonucleoprotein) complexes (U1, U2, U4, U5 and U6), all being important constituents of the spliceosome [10], [11]. Each U-snRNP complex is composed of a single, relatively stable snRNA component in the range of 107–196 nucleotides and, with the exception of the U6 snRNP, a common core of seven proteins, called Sm proteins (D1, D2, D3, E, F, G and the splice variants B/B′), and few unique protein species. The Sm proteins are bound to a conserved single-stranded U-rich region (the Sm site) which is present in U1, U2, U4 and U5 snRNA. With respect to U1 snRNP complex, in addition to the 164 nucleotide long U1 snRNA and Sm proteins, it includes three specific polypeptides; U1A, U1C and U1-70 K. Of the latter, the U1A and U1-70 K bind directly to the U1 snRNA while U1C can only bind to the U1 snRNP particle when U1-70 K and Sm proteins are already associated with the U1 snRNA [12 and references therein]. Several protein components of the spliceosomal U-snRNP complexes are specific and frequent targets of autoantibodies detected in the sera of patients with systemic rheumatic diseases (most common, anti-Sm and anti-U1 RNP autoantibodies). During spliceosome formation, U1 snRNP is the first to associate with the pre-mRNA at the 5′ splicing site, a very critical early step in spliceosome assembly. Afterwards, U2 binding at the vicinity of the 3′ splice site and subsequent entrance of U4/U5/U6 tri-complex follows [10], [11], [12].

A specific class of multifunctional proteins with a potential to act in coupling transcription and splicing are those with ability to bind both RNA and ssDNA. These refer to some known transcription factors that include members of the TET sub-class, as well as splicing factors and hnRNP proteins [13]. The precise role of individual RNA/ssDNA binding proteins in establishing a specific network of interactions is currently not fully explored. The TET proteins, TLS/FUS, EWS and TAF15 (formerly named TAFII68) are relatively abundant nuclear species. They have a highly conserved domain structure that includes the presence of a zinc finger motif, an RNA-binding domain (RBD/RRM) and RGG regions that also participate in RNA binding, characteristic features of multifunctional proteins capable of interacting with both DNA and RNA [14], [15]. An important feature of the TET family members is their participation in chromosomal translocations that lead to expression of fused proteins. The N-terminal part of TLS/FUS, EWS and TAF15 alike can fuse to the DNA-binding domain of specific transcription factors (e.g. CHOP, FLI1, ERG) giving rise to oncoproteins with novel strong transcriptional activator/repressor properties, characteristic of particular cancer cell types [16], [17]. TLS/FUS has been identified as the hnRNP P2 protein, an associated component of hnRNP complexes, important players of the post-transcriptional machinery [18]. Currently, a diverse list of biological roles is ascribed to TLS/FUS that includes its functioning in DNA repair, genomic integrity, regulation of transcription and RNA splicing [19]. In contrast, relatively little is yet known concerning the role of the related EWS and, in particular, TAF15.

TAF15 represents a relatively new TET family member initially characterized as a putative RNA/ssDNA binding protein that was considered to be a specific transcription factor with a suggestive role in transcription initiation and/or elongation [20], [21]. It has been detected in stable association with a subset of TFIID (both TBP-free and TBP-containing) complexes, as well as with RNA pol II [20]. Distinct TFIID complexes containing TAF15, TLS/FUS or EWS proteins have been reported, indicating that these proteins have related but discrete functional properties [21]. As pointed out before [20], about 5–10% of the cellular TAF15 is associated with TBP-containing complexes, thereby raising the question of the extent of its participation in additional nuclear functions. This has led to the speculation that TAF15 might participate, in addition to the pre-initiation complex (PIC) formation with distinct TFIID complexes, in the elongating RNA pol II complex, as well as in a number of protein–RNA interactions with the growing nascent mRNA transcripts [20], [21].

We have conducted studies aiming at defining novel nuclear interactions of TAF15 in human (HeLa) cells, in particular with components of the post-transcriptional apparatus. Recently, we have contributed in a study showing the interaction of TAF15 with the spliceosomal U1 snRNA, in the absence of U1 snRNP specific protein components [22]. We now present new findings that demonstrate the ability of TAF15 to form a complex with a minor fraction of the spliceosomal U1 snRNP complex, as well. Our evidence was based on the application of an extensive range of immunoprecipitation assays (IPs) on nuclear fractions obtained under different extraction protocols, showing the co-precipitation of TAF15 and U1 snRNP specific components (namely, U1 snRNA, U1-70 K and Sm proteins). Moreover, TAF15 was shown to form protein–protein interactions with the U1C protein in in vitro pull-down assays employing purified protein components, and to make direct association with RNA in vivo. Overall, the present study provided additional information on the multifaceted participation of U1 snRNP components in the interplay of factors operating in transcriptional and post-transcriptional events in higher eukaryotes.

Section snippets

Cell-growth and preparation of nuclear fractions

Mass production of exponentially growing HeLa S3 cells was done in suspension cultures of 2–5 l in Joklik's modified MEM supplemented with 10% FCS and antibiotics (penicillin/streptomycin), at 37 °C. Monolayer cultures of HeLa cells incubated in D-MEM, 10% FBS and antibiotics were also used. The parental HeLa cell line and the derived HeLa S3 cells adapted to grow in suspension were from the European Collection of Cell Culture (ECACC). All cells were collected at logarithmic growth, washed

TAF15 is broadly distributed within fractionated nuclei

The present study relied mainly on the availability of a highly specific monoclonal antibody against TAF15 [20]. We initially applied this antibody to explore the nuclear distribution of TAF15 in HeLa cells, using a biochemical fractionation protocol previously described by us [24] that was based on the sequential extraction of isolated nuclei, as schematically outlined in Fig.1Aa. This provided distinct nuclear fractions with an anticipated enrichment in: soluble nuclear material obtained

Discussion

The novel finding presented in this study was the existence of a TAF15-U1 snRNP complex within fractionated HeLa nuclear extracts. This was based on a combination of experimental evidence using a series of IP reactions with antibodies specific for TAF15 and/or components of the spliceosomal U-snRNPs on differentially obtained HeLa nuclear fractions with or without RNase/DNase digestion.

Clear evidence was provided for the co-precipitability of TAF15 and U1 snRNP components from the high-salt

Acknowledgements

We acknowledge the expert technical assistance of Ch. Theodoropoulou, and the tissue culture work of K. Logotheti. We, also, thank M. Ballarino and L. Jobert for critical reading of the manuscript. This work was supported in whole by a Marie Curie TOK-Development project [grant number MTKD-CT-2004-509836] to A.G. and L.T., and, in part, by funds from CNRS (Skin-Chroma) and AICR (09–0258) to L.T.

M.L. and M.M. were Marie Curie post-doctoral fellows in the lab. of A.G.

References (57)

  • L. Jobert et al.

    PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function

    Exp. Cell Res.

    (2009)
  • H.J. Lee et al.

    Stimulation of hTAFII68 (NTD)-mediated transactivation by v- Src

    FEBS Lett.

    (2004)
  • M.N. Manoussakis et al.

    Detection of human-specific anti-La(SSB) antibodies in patients with rheumatoid arthritis

    J. Autoimmun.

    (1995)
  • D.L. Spector

    Nuclear organization of pre-mRNA processing

    Curr. Opin. Cell Biol.

    (1993)
  • D.P. Morris et al.

    The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II

    J. Biol. Chem.

    (2000)
  • H. Tian

    RNA ligands generated against complex nuclear targets indicate a role for U1 snRNP in co-ordinating transcription and RNA splicing

    FEBS Lett.

    (2001)
  • W. O' Gorman et al.

    Analysis of U1 small nuclear RNA interaction with Cyclin H

    J. Biol. Chem.

    (2005)
  • J.Y. Chen et al.

    Specific alterations of U1-C protein or U1 small nuclear RNA can eliminate the requirement of Prp28p, an essential DEAD box splicing factor

    Mol. Cell

    (2001)
  • F. Rossi et al.

    Involvement of U1 small nuclear ribonucleoproteins (snRNP) in 5′ splice site-U1 snRNP interaction

    J. Biol. Chem.

    (1996)
  • T. Maniatis et al.

    An extensive network of coupling among gene expression machines

    Nature

    (2002)
  • D.L. Bently

    Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors

    Curr. Opin. Cell Biol.

    (2005)
  • I. Listerman et al.

    Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells

    Nat. Struct. Mol. Biol.

    (2006)
  • H.P. Phatnani et al.

    Phosphorylation and functions of the RNA polymerase II CTD

    Genes Dev.

    (2006)
  • Z. Zhou et al.

    Comprehensive proteomic analysis of the human spliceosome

    Nature

    (2002)
  • J. Deckert et al.

    Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions

    Mol. Cell. Biol.

    (2006)
  • M. Ladomery

    Multifunctional proteins suggest connections between transcriptional and post-transcriptional processes

    Bioessays

    (1997)
  • A.Y. Tan et al.

    The TET family of proteins: functions and roles in disease

    J. Mol. Cell. Biol.

    (2009)
  • A. Bertolotti et al.

    The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties

    Oncogene

    (1999)
  • Cited by (24)

    • TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex

      2022, Cell Reports
      Citation Excerpt :

      Besides a specialization of binding onto the core promoter of genes, TAF15 may interact not only with RNA but also single-strand DNA because it contains an RNA-binding domain (Bell and Tora, 1999). TAF15 also functions in coupling transcription with RNA processing by associating with the spliceosomal U1 small nuclear ribonucleoprotein particle (snRNP) complex (Leichter et al., 2011). The N-terminal domain of TAF15 has transactivation and oncogenic properties (Bertolotti et al., 1999).

    • Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease

      2019, Cell Reports
      Citation Excerpt :

      Mutation of SMN, encoding an essential cofactor for snRNP biogenesis, causes the recessive neurodegenerative disease spinal muscular atrophy (Lefebvre et al., 1995; Lorson et al., 1999). More recently, genetic variants affecting numerous RNA-binding protein splicing factors have been identified in familial FTD-ALS (Ito et al., 2017), and most of these proteins, including TDP-43, FUS, TAF15, TIA1, and hnRNPA2B1, closely associate with the spliceosome complex (Förch et al., 2002; Freibaum et al., 2010; Leichter et al., 2011; Martinez et al., 2016; Sun et al., 2015). In the Drosophila nervous system, Tau induced a similar profile of splicing errors as SmB loss of function, and genetic manipulation of numerous core snRNP components enhanced Tau toxicity.

    • A novel role of U1 snRNP: Splice site selection from a distance

      2019, Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
      Citation Excerpt :

      In addition to the spliceosome, U1 snRNP is detected in the supraspliceosome, a high-order pre-assembled macromolecular complex comprised of four spliceosomes, each containing all five U snRNPs [56,57]. Other RNA:protein complexes associated with transcription and/or transcription-coupled events also harbor U1 snRNP [58–61]. The idea that U1 snRNP recognizes the 5′ss through base pairing was first put forward in 1980 [62,63], and experimentally validated in 1986 [64].

    • From intronization to intron loss: How the interplay between mRNA-associated processes can shape the architecture and the expression of eukaryotic genes

      2017, International Journal of Biochemistry and Cell Biology
      Citation Excerpt :

      Additional hypotheses about the dominance of SFs or CPFs within the nascent transcript may be generated when focusing on the U1 splicing complex. Not only does 5′ ss-bound U1 play an important role in splicing, telescripting, transcription elongation and transcription termination (Fong and Zhou, 2001; Gunderson et al., 1994; Kaida et al., 2010; Seraphin and Rosbash, 1989), it also modulates the rate of transcription initiation by RNA polymerase II via its association with general transcription factors (Boque-Sastre et al., 2015; Kwek et al., 2002; Leichter et al., 2011; Spiluttini et al., 2010). Furthermore, promoter-proximal 5′ ss-bound U1s enhance transcriptional activity (Damgaard et al., 2008; Furger et al., 2002; Palmiter et al., 1991) and associate with a reduced frequency of antisense transcription (Bieberstein et al., 2012).

    View all citing articles on Scopus
    1

    Present address: Michael Leichter, Rheinische Akademie, Koeln, Vogelsanger Strasse 295, 50825 Koeln, Germany.

    View full text